Home
Awards
Events
Features
An author's perspective
Ask the Experts
Conference reports
eBooks
Expert opinion
In the Zone
Journal articles
Journal content
Spotlights
Tech Digest
Follow us on social media
Glossary
Topics
Applications
Advanced therapies
Biomarkers
Clinical
Diagnostics
Drug development
Forensic
Patient-centric sampling
Sports drug testing
Toxicology
Vaccines
Industry updates & regulations
Biopharmaceuticals
Collaborations & mergers
Data processing & interpretation
Regulated bioanalysis
Molecules
Antibodies | ADCs
Biosimilars
Large
Metabolites
Oligonucleotides
Small
Techniques
Automation
Chromatography
Imaging
LBA
Microsampling
MS (LC–MS/MS, HRMS, IMS)
Sample preparation
Follow us on social media
Multimedia
Coffee chats
Infographics
Interviews
Panel discussions
Podcasts
Videos
Webinars
Follow us on social media
News
Partners
Register
Key qualities to ensure success when outsourcing immunogenicity assay development
23 Oct 2019
Biomarkers
Clinical
Diagnostics
Immunogenicity
< Back to – In the Zone: Immunogenicity
Share
Previous article
Next article
Related articles
7 MAR 2017
NEWS
Pharmaceutical Product Development (PPD) announces fifth renewal of contract with National Institutes of Health
20 FEB 2017
DRUG DEVELOPMENT
Current trends in pharmaceutical outsourcing of bioanalysis
28 NOV 2014
NEWS
Gold standard: potential new assay to detect influenza virus
15 APR 2014
AUTOMATION
Laboratory automation of high-quality and efficient ligand-binding assays for biotherapeutic drug development
31 AUG 2009
COLLABORATIONS AND MERGERS
Incurred sample reproducibility: views and recommendations by the European Bioanalysis Forum
11 SEP 2012
COLLABORATIONS AND MERGERS
Updates from the EBF DBS–microsampling consortium